Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma

Table 1 p42.3 status in relation to clinicopathological features in patients with hepatocellular carcinoma (n = 138) n (%)

Tissues parameters	No. of cases	Positive	Negative	P value
Gender				NS
Male	98 (71.0)	42 (42.9)	56 (57.1)
Female	40 (29.0)	23 (58.0)	17 (42.0)
Age at diagnosis (yr)				NS
< 60	117 (84.8)	52 (44.4)	63 (55.6)
≥ 60	21 (15.2)	12 (57.1)	9 (42.9)
Carcinoma and adjacent tissue				0.0008
Carcinoma tissue	138 (54.8)	96 (69.6)	42 (30.4)
Adjacent tissue	114 (45.2)	35 (30.7)	79 (69.3)
Degree of differentiation				0.031
Well	42 (30.4)	11 (26.2)	31 (73.8)
Moderate	87 (63.0)	39 (44.8)	48 (55.2)
Poor	9 (6.5)	6 (66.7)	3 (33.3)
TNM classification				NS
Stage I/II	101 (73.2)	43 (42.6)	58 (57.4)
Stage III/IV	37 (26.8)	19 (51.4)	18 (48.6)
HBV				NS
Negative	41 (29.7)	15 (36.6)	26 (63.4)
Positive	97 (70.3)	47 (48.5)	50 (51.5)
Type of hepatoma				NS
Nodular	94 (68.1)	44 (46.8)	50 (53.2)
Massive	35 (25.4)	13 (37.1)	22 (62.9)
Diffuse	9 (6.5)	5 (55.6)	4 (44.4)

TNM: Tumor-node-metastasis; NS: Not significant; HBV: Hepatitis B virus.